论文部分内容阅读
目的观察雾化吸入盐酸氨溴索(沐舒坦)联合头孢曲松钠治疗老年慢性支气管炎的临床效果。方法选取该院2014年8月-2015年8月收治的老年慢性支气管炎患者80例,运用双色球随机分组法分为观察组和对照组各40例,观察组采用雾化吸入沐舒坦联合头孢曲松钠治疗,对照组采用头孢曲松钠治疗。观察2组患者的临床疗效,比较2组患者排痰量、血氧饱和度、住院时间。结果观察组总有效率为95.0%显著高于对照组的75.0%,患者排痰量多于对照组,血氧饱和度水平高于对照组,住院时间显著短于对照组,差异均有统计学意义(P<0.05)。结论在老年慢性支气管炎治疗过程中,雾化吸入沐舒坦联合头孢曲松钠治疗可有效缓解患者临床症状,提高治疗有效率,增加患者排痰量,减轻患者不适,加快康复速度,值得临床推广应用。
Objective To observe the clinical effect of ambroxol ambroxol hydrochloride combined with ceftriaxone sodium on senile chronic bronchitis. Methods Eighty elderly patients with chronic bronchitis admitted from August 2014 to August 2015 in our hospital were divided into observation group and control group by using two-color ball randomization method. The observation group was treated with inhalation of cefotaxime Sodium treatment, the control group treated with ceftriaxone sodium. The clinical efficacy of the two groups were observed. The sputum volume, oxygen saturation and hospital stay in two groups were compared. Results The total effective rate was 95.0% in the observation group was significantly higher than 75.0% of the control group, the patient sputum volume more than the control group, oxygen saturation level was higher than the control group, hospitalization was significantly shorter than the control group, the difference was statistically significant Significance (P <0.05). Conclusion During the treatment of senile chronic bronchitis, inhalation of mucosolvan by inhalation combined with ceftriaxone sodium can effectively relieve the clinical symptoms, improve the treatment efficiency, increase the sputum volume of patients, relieve the discomfort and accelerate the recovery of patients, and worthy of clinical promotion application.